Search results for: 'diagnostics dual and alliance'
- Did you mean
- diagnostics deal and alliances
- Related search terms
- diagnostics deal alliance
- diagnostics data and alliances
- diagnostics data and alliance
- diagnostics collaborative
- diagnostics collaboration
-
Hematology Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Hematology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Musculoskeletal Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Musculoskeletal Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2025
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More -
Psychiatry Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Psychiatry Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Metabolic Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More -
Generic Pharmaceutical Partnering Terms and Agreements 2010-2026January 2026$3,995.00Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals.
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
-
Infectious Vaccine Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
